Adrenocortical Carcinoma: all 94 studies
Page 1 of 1. Open to participants first (26), then studies with results posted, then the rest; newest registration first within each.
- STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL)Not yet recruitingNCT07743138Phase 2
- Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump TherapyNot yet recruitingNCT07715903Phase 1
- Characterization of the Strasbourg Cohort of Patients With Adrenal Cortex CarcinomaRecruitingNCT07335679
- A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate CancerRecruitingNCT07189403Phase 1
- A Prospective, Randomized, Multicenter Clinical Study Comparing Adjuvant Radiotherapy Versus Observation in High-risk Localized Adrenocortical Carcinoma After Surgery.Not yet recruitingNCT07141147Not applicable
- Cemiplimab as Maintenance Treatment for Advanced Adrenocortical CancerRecruitingNCT07085572Phase 2
- Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical CancerRecruitingNCT06900595Phase 2
- Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical CarcinomaRecruitingNCT06831175Phase 2
- Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical CarcinomaRecruitingNCT06587802Phase 2
- Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical CarcinomaRecruitingNCT06487481Phase 1
- Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSIRecruitingNCT06333314Phase 2
- Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World DataRecruitingNCT06229405
- Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)RecruitingNCT06141369Not applicable
- Study of Radiotherapy and Pembrolizumab in People With Adrenocortical CarcinomaRecruitingNCT06066333Phase 2
- Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted AdrenalectomyRecruitingNCT06050057
- A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath TumorsRecruitingNCT06041516Phase 1
- Cabozantinib in Combination With Pembrolizumab for the Treatment of Patients With Locally Advanced, Metastatic, or Unresectable Adrenal Cortical CancerRecruitingNCT06006013Phase 2
- Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)RecruitingNCT05913427Phase 2
- The Adverse Event of Mitotane Therapy in Patients With Adrenocortical CarcinomaNot yet recruitingNCT05839886
- PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical CarcinomaRecruitingNCT05286814Phase 2
- Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical CarcinomaRecruitingNCT04318730Phase 2
- Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsRecruitingNCT04119024Phase 1
- A Prospective Cohort Study for Patients With Adrenal DiseasesEnrolling by invitationNCT03474237
- Familial Investigations of Childhood Cancer PredispositionRecruitingNCT03050268
- Adrenal Tumors - Pathogenesis and TherapyRecruitingNCT00669266
- German Adrenocortical Carcinoma RegistryRecruitingNCT00453674
- A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical CarcinomaTerminatedNCT05634577Phase 2Results posted
- Milademetan in Advanced/Metastatic Solid TumorsTerminatedNCT05012397Phase 2Results posted
- A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/ParagangliomaTerminatedNCT04187404Phase 1/2Results posted
- Cabozantinib in Treating Patients With Locally Advanced or Metastatic Unresectable Adrenocortical CarcinomaCompletedNCT03370718Phase 2Results posted
- Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare TumorsActive, not recruitingNCT02867592Phase 2Results posted
- Nivolumab in Treating Patients With Metastatic Adrenocortical CancerTerminatedNCT02720484Phase 2Results posted
- Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical CarcinomaActive, not recruitingNCT02673333Phase 2Results posted
- Study of Efficacy and Safety of Osilodrostat in Cushing's SyndromeCompletedNCT02468193Phase 2Results posted
- Surgery and Heated Chemotherapy for Adrenocortical CarcinomaCompletedNCT01833832Phase 2Results posted
- Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-Pathway in Metastatic, Recurrent or Primary Unresectable Adrenocortical CancerCompletedNCT01255137Phase 2Results posted
- Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By SurgeryCompletedNCT00848016Phase 2Results posted
- Cixutumumab in Treating Patients With Relapsed or Refractory Solid TumorsCompletedNCT00831844Phase 2Results posted
- IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by SurgeryTerminatedNCT00778817Phase 2Results posted
- Sunitinib in Refractory Adrenocortical CarcinomaCompletedNCT00453895Phase 2Results posted
- Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical TumorCompletedNCT00304070Phase 3Results posted
- Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)CompletedNCT00094497Phase 3Results posted
- Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical CancerCompletedNCT00071058Phase 2Results posted
- Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland CancerTerminatedNCT00003453Phase 2Results posted
- Phase 1 Study of 68Ga-R8760TerminatedNCT05999292Phase 1
- European Multicenter Study on Role of Lymph Node Dissection in Surgical Management of Adrenal Cortical CarcinomaStatus unknownNCT05763524
- Adrenal Vein Sampling as a Tool to Identify Biomarkers That Aid the Diagnosis of Adrenocortical CarcinomaStatus unknownNCT05660889
- Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.Active, not recruitingNCT05563467Phase 2
- First-in-human Evaluation of [18F]CETOCompletedNCT05361083Early Phase 1
- The Impact of Mitotane Therapy on Serum Free Proteins in Patients With Adrenocortical CarcinomaCompletedNCT05344027
- Phase II Trial of Pembrolizumab Plus Lenvatinib in Advanced Adrenal Cortical CarcinomaActive, not recruitingNCT05036434Phase 2
- VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal CarcinomaStatus unknownNCT04666220
- Natural History Study of Children and Adults With Adrenocortical Cancer (ACC)TerminatedNCT04447014
- Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)CompletedNCT04373265Phase 1
- Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)Active, not recruitingNCT04358107
- A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC)Active, not recruitingNCT03833700Phase 1
- A Phase 1 Study of [225Ac]-FPI-1434 InjectionTerminatedNCT03746431Phase 1
- Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInomaCompletedNCT03723941Phase 3
- Cabozantinib in Advanced Adrenocortical CarcinomaActive, not recruitingNCT03612232Phase 2
- Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing SyndromeActive, not recruitingNCT03604198Phase 2
- Circulating Tumor DNA Exposure in Peripheral BloodStatus unknownNCT03517332
- Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary TumorsActive, not recruitingNCT03333616Phase 2
- Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy LinesStatus unknownNCT03257891Phase 2
- Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical CarcinomaStatus unknownNCT03145285Phase 2
- Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical CarcinomaActive, not recruitingNCT03127774Phase 2
- Nivolumab and Ipilimumab in Treating Patients With Rare TumorsActive, not recruitingNCT02834013Phase 2
- Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine TumorWithdrawnNCT02831179Phase 1
- A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549Status unknownNCT02637531Phase 1
- Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing YieldCompletedNCT02324647
- Natural History and Tissue Acquisition Study of Adrenocortical CarcinomaCompletedNCT02015026
- Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical CarcinomaCompletedNCT01898715Phase 1
- Possible New Therapy for Advanced CancerTerminatedNCT01832974Phase 1
- Studying Genes in Samples From Younger Patients With Adrenocortical TumorCompletedNCT01528956
- Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical CarcinomaCompletedNCT01514526Phase 2
- A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) PatientsCompletedNCT01262235Phase 1/2
- Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesCompletedNCT01048892Phase 1
- A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical CarcinomaCompletedNCT00924989Phase 3
- Sorafenib Plus Paclitaxel in Adreno-Cortical-Cancer PatientsStatus unknownNCT00786110Phase 2
- Efficacy of Adjuvant Mitotane Treatment (ADIUVO)Status unknownNCT00777244Phase 3
- Evaluation of Side Effects of MitotaneActive, not recruitingNCT00568139
- Treatment Study Using Bevacizumab for Patients With Adrenocortical CarcinomaWithdrawnNCT00469469Phase 2
- Preclinical Study Towards an Immunotherapy in Adrenocortical CarcinomaActive, not recruitingNCT00457587
- Evaluation of 123I-Iodometomidate for Adrenal ScintigraphyCompletedNCT00454103Phase 1/2
- Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal ImagingCompletedNCT00445718
- Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal CancerCompletedNCT00436657Phase 1
- Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic CancerCompletedNCT00436410Early Phase 1
- Trial With Taxotere and Cisplatin in Non-operable Adrenocortical CarcinomaCompletedNCT00324012Phase 2
- Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)CompletedNCT00215202Phase 2
- Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00091182Phase 2
- Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuCompletedNCT00004074Phase 1
- Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid TumorsCompletedNCT00003038Phase 1
- S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by SurgeryTerminatedNCT00002921Phase 2
- Combination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsCompletedNCT00002608Phase 2
- A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical ResectionCompletedNCT00001339Phase 2